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ABSTRACT. Revascularization of the left anterior descending coronary artery is an important, evolving
and controversial topic. There are differences in patient selection, hospital stay and readmission, and
hospital cost.
We reviewed our institutional experience in 190 consecutive patients who underwent isolated initial
left anterior descending revascularization via angioplasty, angioplasty plus stenting, conventional
coronary artery bypass grafting and minimally invasive direct coronary artery bypass. We sought to
determine if there were differences in patient demographics, clinical outcomes, and resource utilization.
We sought to evaluate what were the principal determinants of any measured differences in outcome.
Inpatient and outpatient chart review, evaluation of hospital cost via micro cost method, and
multivariate analysis were employed. Results with p <0.05 were considered significant by conventional
statistical analysis.
Mortality was equal in all subgroups. Patients who underwent percutaneous revascularization had a
shorter initial length of hospital stay and initial hospital cost. This was particularly true among those
who received stents. Patients who received surgical therapy were less likely to require repeat hospital
admission for both cardiac and noncardiac indications. During follow up, the initial resource savings
attributable to percutaneous interventions dissipated. Multivariate analysis indicated that measured
differences were likely attributable to differences in patient baseline demographics rather than the
choice of revascularization procedure.
Though there are differences in resources, as measured by hospital days or hospital costs between
patients undergoing LAD revascularization via different techniques, the differences are principally due to
differences in the types of patients selected for these techniques rather than the revascularization
procedure.
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INTRODUCTION
The optimal revascularization technique for clinically
important coronary artery disease is controversial. A
variety of clinical studies have evaluated the relative
effectiveness of coronary angioplasty, coronary
atherectomy, and standard coronary artery bypass
grafting (Versaci and others 1997; King III and others
1997; Tu and others 1997; Gersh 1997; Mariani and
others 1997; Frierson and others 1992; Hueb and others
1995; RITA Trial Participants 1993; Cameron and others
1994). While traditionally the most weight is given to ran-
domized prospective studies, their clinical usefulness is
often limited because of marked changes in clinical
practice that can occur with time, making the results of
the studies out of date by the time the results are known
and disseminated. Retrospective analyses of clinical
databases have proven particularly useful in this field,
and may help with clinical decision making both at
individual institutions and more generally. The clinical
care of patients is decided by the responsible physicians
in accord with their best judgment and analyzed
subsequently. While such studies have their own limi-
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tations, their timeliness may be more directly relevant to
contemporary clinical practice. There have been several
studies evaluating optimum revascularization strategies
in multivessel disease, as well as some for single-
vessel coronary artery disease (Versaci and others 1997;
Gersh 1997; Mariani and others 1997; Frierson and
others 1992; Hueb 1995; Cameron and others 1994;
Goy and others 1994). Of patients with single-vessel
disease, it is generally believed that isolated left anterior
descending coronary disease carries the worst prog-
nosis. Revascularization techniques have undergone
major changes in the last several years with the de-
velopment and use of intracoronary stents and minimally
invasive direct coronary artery bypass surgery
(MIDCAB) (Versaci and others 1997; Mariani and others
1997; Carrozza and Bairn 1997; Bauters and others 1997;
Moussa and others 1997). The purpose of this study was
to analyze our single institutional experience with
patients who have undergone isolated LAD coronary
revascularization. We focused on this group of patients
because of their clinical importance, the true uncertainty
as to optimal revascularization strategies, and the fact
that focusing on this particular group of patients may
provide a degree of clinical homogeneity that might
better help elucidate the role of revascularization
strategy, rather than incompletely accounted for dif-
ferences in patient populations.
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METHODS
All patients undergoing single-vessel left anterior
descending coronary revascularization by angioplasty
between 1 January 1995 and 31 December 1996 were
included in our analysis. The time window for MIDCAB
and CABG was extended to 31 March 1997 so as to facil-
itate patient accrual. The choice of revascularization tech-
nique was determined by the patient after discussion
with their cardiologist and surgeon. Patient and pro-
cedure demographic data were recorded prospectively
in a proprietary database (Summit Medical System) on
all patients. The presence and severity of coronary steno-
sis was determined by a visual estimation of percent
diameter, as is our typical clinical practice. Complications
were recorded contemporaneously in the medical record
as well as determined via retrospective chart review.
The occurrence of hospital readmission and/or repeat
revascularization procedure was determined via review
of our institutional medical records as well as via con-
tact with the patient's primary physician and/or cardi-
ologist. The indication for repeat admission was de-
termined primarily by the attending physician during
the readmissions, and subsequently reviewed by one of
the investigators. In cases of disagreement, the medical
record was reviewed by other physicians for a con-
sensus decision.
To focus the study on a homogenous group of
patients, where the choice of surgical versus angioplasty
procedure is commonly a real one, patients who under-
went revascularization within the first 24 hours of an
acute myocardial infarction were excluded. These
patients typically underwent direct angioplasty or rescue
angioplasty, and it is very rare in our institution and
other institutions for these patients to have emergency
surgery. Because we wish to assess the implications of a
choice of revascularization strategy, and not just the
isolated procedure, only patients presenting for initial
revascularization of the LAD during the study period
were included; patients who presented during our study
interval with LAD restenosis were excluded.
Cost analysis was determined using micro-cost
accounting. The micro-cost data system allows accurate
costing of personnel, supplies, or time, and equipment
on a per procedure, per physician basis.
Statistical analysis was performed utilizing statistical
analysis for the Social Sciences (SAS). A students' /-test
for continuous variables, correlational matrix for uni-
variate analysis, and multiple linear regression analysis
were used. Statistical significance was conventionally
defined as p <0.05. Corrections were made for multiple
comparisons. (McNeil and others 1996) Power analysis
was run for an effect size (f2) equaling 0.15, which has
been identified by Cohen as a medium effect size for
alpha equal to 0.05 and a population size (N) of 193
(McNeil and others 1996; Cohen 1977). Power analysis
was run for the most conservative regression model,
which had seven linearly independent vectors. For a
medium effect (f2 = 0.15) (Cohen 1977) we will be able
to detect that effect 98 times out of 100. However, for
a small effect, we would only be able to detect that effect
27 times out of 100 when N was 193 and alpha was 0.05.
Also, the Bonferroni correction was used to control
for Type I error build-up due to multiple tests of sig-
nificance. The Bonferroni correction would indicate that
a p-value less than or equal to 0.008 would be needed
to produce significance at the 0.05 level.
RESULTS
Demographics
Follow up data was available on 100% of patients.
There were no deaths. Baseline demographics are de-
scribed in Table 1. Patients undergoing conventional
coronary artery bypass grafting were slightly older than
those undergoing MIDCAB or PTCA. Those greater than
75 years of age comprised 17%, 28%, and 24% of PTCA,
CABG, and MIDCAB respectively. The patients were pre-
dominantly male, particularly those undergoing surgical
procedures. As might be expected in a population con-
sisting of patients with single-vessel coronary artery
disease, clinical congestive heart failure was relatively
uncommon, comprising less than 10% of the patients.
One-fifth of the total patient population had diabetes
mellitus.
Clinical Results
Clinical results including mortality, need for target
vessel (that is, repeat LAD) revascularization (TVR),
need for hospital readmission, and length of hospital
stays are presented in Table 2. Readmissions were far
more common in patients undergoing angioplasty than
undergoing either of the surgical procedures. This was
true even when the analysis was restricted to those
readmissions for predominantly cardiac problems. The
initial length of stay was much lower for angioplasty
than for surgical revascularization, though the likelihood
of a patient being readmitted for cardiac reasons was
increased. There were three noncardiac readmissions
out of a total of 17 MIDCAB patients. The small sample
size precludes a definitive interpretation of this num-
ber. Including the index hospitalization as well as any
follow up hospitalizations, patients undergoing angio-
plasty spent an average of 7.13 days in the hospital,
those undergoing CABG 10.44 days, and those under-
going MIDCAB 8.88 days. Some of this time is attribut-
able to the presenting medical condition (for example,
acute myocardial infarction) and not solely the re-
vascularization procedure. In sum, the initial benefit
that percutaneous procedures, and to some extent
MIDCAB, possess for a shortened hospital stay is dissi-
pated with time. The need for repeat hospital admissions
dramatically reduces the disparity in hospital stays be-
tween the various revascularization strategies.
Of the 155 patients who underwent percutaneous re-
vascularization, 134 did not receive a stent, and 21
received one or more intracoronary stents. Data com-
paring baseline demographics are listed in Table 1. Data
describing need for repeat admissions, repeat cardiac
admission, and target vessel revascularizations is pre-
sented in Table 2. Stent patients were generally older
and more likely to be female than patients who did not
receive a stent. Patients who receive a stent were roughly
half as likely to require (clinically driven) target vessel
revascularization (9-5% vs. 21.6%).
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TABLE 1
Patient demographics.
# of Patients
Median Age
# > = 65 yrs
% > = 65 yrs
# > = 75 yrs
% > = 75 yrs
# male
% male
Comorbidities
# with diabetes
% with diabetes
# with hypertension
% with hypertension
# with clinical CHF
% with clinical CHF
# with any/all of the above
% with any/all of the above
PTCA
w/Stent
21
73
20
95.24%
5
23.81%
10
47.62%
4
19.05%
11
52.38%
2
9.52%
12
57.14%
PTCA
w/o Stent
134
59
48
35.82%
21
15.67%
82
61.19%
29
21.64%
60
44.78%
10
7.46%
79
58.96%
PTCA
Total
155
62
68
43.87%
26
16.77%
92
59.35%
33
21.29%
71
45.81%
12
7.74%
91
58.71%
CABG
18
68
10
55.56%
5
27.78%
12
66.67%
3
16.67%
8
44.44%
2
11.11%
11
61.11%
Mid-CAB
17
61
6
35.29%
4
23.53%
15
88.24%
2
11.75%
4
23.53%
1
5.88%
5
29.41%
Patients who received a stent likely differed in clini-
cally important ways from those who did not, often in
a manner not adequately captured in our database. At
the point in time when this data was collected, patients
who are a part of this study (a subset of all patients
receiving angioplasty and/or stenting) were more likely
to receive a stent for "bail-out" or threatened vessel
closure. In the short time since this study was under-
taken our laboratory, as well as others, are more likely
to put stents in patients after balloon angioplasty, even
when acute occlusion is not imminent. Our most recent
review indicates more than 80% of all interventional
patients in our catheterization laboratory receive stents.
Hospital Cost Analysis
Hospital cost data is presented in Table 3. Initial
hospital costs were lower for patients undergoing
percutaneous revascularization than those undergoing
surgical revascularization. The initial cost for patients
receiving a stent was higher than those undergoing per-
cutaneous revascularization without a stent. MIDCAB
was initially less costly than conventional CABG. The ini-
tial advantage of lower cost in the percutaneous group
is diminished with time due to hospital readmissions. In
this particular study, cost analysis correlated with length
of stay (LOS) analysis; increased LOS was associated
with increased cost (Marrin and others 1997).
Multiple Regression and Subgroup Analysis
The above data demonstrate that there exists sub-
stantial differences in length of stay and hospital costs
for patients undergoing PTCA versus patients under-
going CABG or MIDCAB. To determine if these differ-
ences were due to differences in patient selection or the
choice of procedure, multiple regression analyses were
performed. This demonstrated that for both total LOS
or total cost as the dependent variable (outcome) the
choice of procedure did not account for a significant
amount of variance if comorbidities are controlled for
(p = 0.44 for LOS, p = 0.15 for cost). This is true for the
measured comorbidities taken in aggregate or indi-
vidually, though there was a nonsignificant trend for
congestive heart failure to correlate with the outcome of
LOS. Importantly, the occurrence of multiple comor-
bidities correlates with increased total LOS and total
cost, and multiple comorbidities were more prevalent in
surgical than angioplasty patients.
At least two studies (Chaitman and others 1997; King
1997) have evaluated the particular adverse outcome of
revascularization of multivessel CAD in diabetics. We
analyzed this important subgroup in our study. If
baseline demographics and comorbidities were held
constant, there was no difference in total LOS or total
costs between percutaneous and either of the surgical
procedures in diabetics.
Elderly patients are an important clinical subgroup
that often presents a therapeutic challenge. Multiple
regression analysis in the elderly ( > 75 or > 65 years)
demonstrated results that were analogous to the over-
all study results. If baseline demographics and
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TABLE 2
Clinical outcomes.
PTCA
w/Stent
PTCA
w/o Stent
PTCA
Total
CABG Mid-CAB
Initial LOS - Median
Initial LOS - Mean
# of Deaths
% of Patients readmitted
Total # of Readmits for group
Total # of Cardiac readmits for group
% of Readmits for cardiac reasons
# of Readmits for TVR
% of Patients readmitted for TVR
Median LOS of Strategy -
Total (incl. any/all readmit)
2
4.95
0
47.6%
15
5
33.3%
2
9.5%
7
4
4.67
0
40.2%
80
62
77.5%
29
21.6%
5
4
4.71
0
41.1%
95
67
70.5%
31
20.0%
5
9
10.06
0
11.1%
2
0
0.0%
0
0.0%
9.5
7
7.71
0
23.5%
5
2
40.0%
0
0.0%
7
Mean LOS of Strategy -
Total (incl. any/all readmit)
Median LOS of Strategy -
Cardiac readmit (incl. all initial)
Mean LOS of Strategy -
Cardiac readmit (incl. all initial)
10.1 6.7 7.1 10.4
10.1
8.9
comorbidities are accounted for, there is no significant
difference in either total LOS or total cost between the
revascularization techniques in the elderly.
DISCUSSION
The optimal current revascularization technique for
patients with isolated left anterior descending coronary
stenosis is uncertain (Versaci and others 1997; King III
and others 1997; Gersh 1997; Hueb and others 1995;
RITA 1993; Hlatky 1996). The clinicians caring for the
patients in our study presumably made the best decision
they could given the available clinical information and
prior institutional experience. Our institution is broadly
representative of others in America. It is a university-
affiliated, (Northeast Ohio Universities College of
Medicine) not for profit community hospital. There are
a total of 530 medical-surgical-obstetric beds, with no
pediatrics or psychiatry. Our active cardiac catheteri-
zation laboratory (approximately 1000 interventional
procedures annually) uses a broad spectrum of cur-
rently available interventional techniques, including
balloon angioplasty, intracoronary stents, and direc-
tional and rotational atherectomy. No investigational
devices were employed during the time period of this
study. Our cardiac surgical program is active and employs
recent surgical advances, including mitral valve repair
and MIDCAB. All of the cardiothoracic surgeons and
interventional cardiologists were board eligible/board
certified. Patients generally presented directly to our in-
stitution or were referred from outlying institutions for
evaluation and treatment of their clinical cardiac con-
dition, rather than being referred for a specific cardiac
procedure. Thus, the results of our single institutional
experience may be of direct relevance to many other
similar programs. It would appear that in this important
group of patients, with single-vessel coronary artery
disease, coronary revascularization can be done with
a very high degree of efficacy and safety. Initial lengths
of hospital stay are generally short, and in our current
healthcare environment may decrease further. In ac-
cord with prior studies in multi-vessel CAD, the initial
lengths of stay and initial costs are generally less for
catheter based interventions, though the number and
costs of repeat revascularization tend to minimize this
initial advantage.
Importantly, patients were not randomized to which
therapy they received. This fact must be borne in mind
in interpretation of all the data, but perhaps particularly
in the subgroups of patients who underwent PTCA. The
use of intracoronary stents is an area of rapid change and
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TABLI<: 3
Rcso 11 rcc 111 ilizulio 11.
PTCA
w/Stent
P'I'CA
w/o Stent
PTCA
Total
CABC. Mid-CAB
Initial Median Cost
Initial Mean Cost
Median Cost of Strategy -
Cardiac readmit (incl. all initial)
Mean Cost of Strategy —
Cardiac readmit (incl. all initial)
Median Cost of Strategy -
Total (incl. any/all readmit)
$8,335
$11,175
$9,473
$12,815
$11,428
$10,139
$10,493
$11,747
$13,841
$11,873
$9,768
$10,586
$11,542
$13,702
$11,851
$20,954
S 21,309
$20,954
$21,309
$20,954
$14,779
$16,342
$14,450
$17,028
$15,764
Mean Cost of Strategy -
Total (incl. any/all readmit) $17,561 $14,557 $14,964 $21,704 $18,027
growth. In our laboratory, as well as most other active
laboratories throughout the country, the indications for
the placement of intracoronary stents broaden con-
tinually and the fraction of patients receiving intra-
coronary stents continues to increase. Nevertheless, it
appears that our data would indicate that patients who
receive intracoronary stents are approximately half as
likely to have clinically needed target vessel re-
vascularization during the follow up period. As this field
evolves, and as the price of stents decreases, it may be
expected that the overall clinically favorable results
seen with intracoronary stenting will be reflected in an
overall shorter length of stay, and an overall lower cost.
Future studies of this evolving field will be necessary to
see if this hypothesis is true.
There are several limitations to our study design.
Patients were not randomized to revascularization tech-
nique, rather it was determined by clinical judgment.
However, this may enhance the overall generalizability
of our findings. It has been shown, for example, that
patients from the EAST registry (where revascularization
strategy was determined by the clinicians and patients,
rather than by randomization) fared better than those
whose revascularization techniques were chosen by
randomization. Even in a study such as this one where
13-3% of patients received intracoronary stents, data
may not be translatable into today and tomorrow's clini-
cal decision making. Nevertheless, the results are fairly
current and there have been no dramatic changes in
recent interventional practices. MIDCAB is a new and
still evolving surgical procedure; there is almost surely
a learning curve, both for the individual surgeon and
the institution. Exactly where, if ever, that curve tends to
plateau, is undefined and the results of our initial small
group of patients may be less favorable than the future
use of this technique. This study represents our insti-
tution's initial experience with MIDCAB. Our follow up
time is limited; this is necessitated by the desire to have
data that is current. Nevertheless, the vast majority of
angioplasty patients were studied for six months after
the procedure, a time when most clinical restenosis
and other reasons for readmissions and repeat re-
vascularizations will be manifest. There were several
admissions "early" after bypass surgery. Comparison
with other studies would suggest that the need for
repeat cardiac readmissions on patients undergoing
surgical interventions will be quite low for several
years, though it will undoubtedly increase with time
due to the progressive nature of coronary atherosclerosis
(Mariani and others 1997; RITA 1993; Cameron and
others 1994). Further study of these and other patients,
with particular emphasis on longer term follow up, will
be necessary and informative.
Our study was limited to patients with isolated LAD
revascularization, and excluded patients undergoing
revascularization within the first 24 hours of acute MI
(that is, direct or rescue angioplasty). As such, its gen-
eralization to patients with single-vessel disease in other
territories, or those requiring multi-vessel revasculari-
zation is speculative. Perhaps clinicians could in-
corporate these current results of this study, with prior
data, addressing angioplasty versus surgery for multi-
vessel coronary artery disease to guide clinical decision
making.
SUMMARY AND IMPLICATIONS
Patients with isolated left anterior descending coron-
ary artery disease undergoing nonemergent revas-
cularization may be successfully treated currently with
angioplasty (often with the concomitant use of intra-
coronary stent), conventional CABG, or the new and
evolving technique of MIDCAB. A high degree of success
will likely occur with any procedure, though the surgi-
cal procedures will typically result in a longer length of
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initial hospital stay and initial costs. Patients undergoing
catheter-based techniques will likely require repeat
hospitalizations and revascularizations during follow up
with additional costs. Total costs for the initial hospital-
ization and early follow up hospitalizations and pro-
cedures would be less for patients undergoing catheter-
based techniques; however with time, initial differences
in clinical outcomes and hospital costs are substantially
decreased. It cannot be concluded that choice of re-
vascularization technique accounts for a significant
amount of unique variance in predicting total LOS or
hospital costs, independent of patient characteristics.
Rather, it appears that differences in the type of patients
undergoing LAD revascularization is the predominant
determinant of clinical outcome (total LOS or total cost).
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